Table 2

Contegra™ 1999–2007, follow-up pressure difference and anticoagulation strategy, re-interventions in detail
reference
 N
 peak ΔP in mmHg
 mean ΔP in mmHg
 Anticoagulation strategy
 Percutaneous
 Surgical
 Total Reinterventions
[1]
 55
 unknown
 unknown
 nil
 17
 5
 22
[2]
 67
 17
 8
 aspirin for 6 months
 2
 1
 3
[3]
 100
 18
 unknown
 nil
 0
 4
 4
[4]
 29
 unknown
 unknown
 Aspirin until weighing 5–6 kg
 2
 1
 3
[5]
 20
 unknown
 13 ± 4.8
 Heparinisation and aspirin
 0
 0
 0
[6]
 67
 unknown
 11
 nil
 0
 1
 1
[7]
 30
 unknown
nil
 0
 2
 2
[8]
 15
11.1 ± 4.5
 nil
 0
 0
 0
[9]
 6
 8.5
 24.5 ± 13.1
 aspirin for 3 months max
 0
 5
 5
[10]
 40
 'increased' in 2- unknown otherwise
nil
 0
 3
 3
[11]
 38
 unknown
nil
 0
 0
 0
[12]
 12
 unknown
 12.9 ± 12.3
 nil
 6
 3
 9
[17]
 60
 unknown
aspirin for 6 months
 6
 1
 7
[21]
 62
 unknown
 14
 aspirin for 3 months
 0
 0
 0
[18]
 76
 unknown
aspirin
 4
 0
 4
[22]
 78
 23
 unknown
 Heparinisation and aspirin
 19
 2
 21





56
 28
 84

N: number of patients followed-up

ΔP: Pressure Difference, commonly reported as 'gradient'

Hg: Mercury

PA: pulmonary artery(-ies)

Protopapas and Athanasiou Journal of Cardiothoracic Surgery 2008 3:62   doi:10.1186/1749-8090-3-62